Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects
Clinical trial NCT00550381 · COMPLETED
Trial details
- NCT number
- NCT00550381
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-03-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.